<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34880859</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1664-3224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <PubDate>
              <Year>2021</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in immunology</Title>
          <ISOAbbreviation>Front Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases.</ArticleTitle>
        <Pagination>
          <StartPage>761354</StartPage>
          <MedlinePgn>761354</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">761354</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.761354</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">To analyze the clinical manifestations, imaging, electroencephalography, treatment, and prognosis of 35 cases of autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) in children.</AbstractText>
          <AbstractText Label="METHODS">Children hospitalized in the Department of Neurology, Hunan Children's Hospital, China, between January 2015 and June 2021, owing to autoimmune diseases of the central nervous system were subjected to a cell-based assay (CBA). The assay identified 40 children positive for GFAP-immunoglobulin (Ig)G antibodies in the serum and/or the cerebrospinal fluid. Based on clinical manifestations and imaging characteristics, five children who were only positive for GFAP-IgG antibodies in serum were excluded, and the remaining 35 children were diagnosed with autoimmune GFAP-A. The clinical data derived from the 35 children were retrospectively analyzed.</AbstractText>
          <AbstractText Label="RESULTS">A total of 35 children, including 23 males and 12 females with a mean age of 6.3 ± 0.6 years, manifested clinical symptoms of fever (62.9%), headache (42.9%), convulsions (42.9%), abnormal mental behavior (51.4%), disorders of consciousness (54.3%), visual disturbance (22.9%), ataxia (11.4%), paralysis (40%), and autonomic dysfunction (25.7%). One child exhibited only the clinical symptom of peripheral facial nerve palsy. Eleven out of 35 children were also positive for other antibodies. In addition to the common overlapping autoimmune syndromes, one case of autoimmune GFAP-A also manifested as Bickerstaff's brainstem encephalitis. Linear periventricular enhancement upon MRI was significantly less frequent in children (8.5%) than in adults. In pediatric patients, MRI contrast enhancement was principally seen in the meninges and brain lobes. Although repeated relapse (17.1%) and sequelae symptoms (20%) occurred in some cases, most children showed a favorable prognosis. Spearman's rank correlation showed that the antibody titer was not significantly associated with the severity of the initial disease conditions.</AbstractText>
          <AbstractText Label="CONCLUSIONS">The disease diagnosis in children seropositive for GFAP antibodies only should receive a comprehensive diagnosis based on their clinical symptoms, imaging, electroencephalographic characteristics, and treatment responses. Some patients with relapses should receive repeated gamma globulin and corticosteroid therapy or the addition of immunosuppressants to their therapeutic regimen, and slow-dose tapering of corticosteroids and extended treatment are recommended for patients with overlapping autoimmune syndromes.</AbstractText>
          <CopyrightInformation>Copyright © 2021 Fang, Hu, Jiang, Yang, Liao, Yang and Wu.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Hongjun</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hunan Children's Hospital, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Wenjing</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hunan Children's Hospital, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Zhi</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hunan Children's Hospital, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Haiyan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hunan Children's Hospital, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liao</LastName>
            <ForeName>Hongmei</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hunan Children's Hospital, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Liming</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hunan Children's Hospital, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Liwen</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Hunan Children's Hospital, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Immunol</MedlineTA>
        <NlmUniqueID>101560960</NlmUniqueID>
        <ISSNLinking>1664-3224</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C000628670">GFAP protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005904">Glial Fibrillary Acidic Protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020274" MajorTopicYN="N">Autoimmune Diseases of the Nervous System</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004679" MajorTopicYN="N">Encephalomyelitis</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005904" MajorTopicYN="N">Glial Fibrillary Acidic Protein</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008590" MajorTopicYN="N">Meningoencephalitis</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009187" MajorTopicYN="N">Myelitis</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">GFAP-A</Keyword>
        <Keyword MajorTopicYN="Y">GFAP-IgG antibodies</Keyword>
        <Keyword MajorTopicYN="Y">autoimmune glial fibrillary acidic protein astrocytopathy</Keyword>
        <Keyword MajorTopicYN="Y">children</Keyword>
        <Keyword MajorTopicYN="Y">overlapping autoimmune syndromes</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>9</Day>
          <Hour>7</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34880859</ArticleId>
        <ArticleId IdType="pmc">PMC8645641</ArticleId>
        <ArticleId IdType="doi">10.3389/fimmu.2021.761354</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, et al. . Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis. JAMA Neurol (2016) 73(11):1297–307. doi: 10.1001/jamaneurol.2016.2549
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2016.2549</ArticleId>
            <ArticleId IdType="pubmed">27618707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang KK, Yang Z, Yue JK, Zhang Z, Winkler EA, Puccio AM, et al. . Plasma Anti-Glial Fifibrillary Acidic Protein Autoantibody Levels During the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study. J Neurotrauma (2016) 33:1270–7. doi: 10.1089/neu.2015.3881
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/neu.2015.3881</ArticleId>
            <ArticleId IdType="pmc">PMC4931336</ArticleId>
            <ArticleId IdType="pubmed">26560343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, et al. . Glial Fibrillary Acidic Protein Immunoglobulin G as Biomarker of Autoimmune Astrocytopathy: Analysis of 102 Patients. Ann Neurol (2017) 81(2):298–309. doi: 10.1002/ana.24881
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.24881</ArticleId>
            <ArticleId IdType="pubmed">28120349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, et al. . Autoimmune GFAP Astrocytopathy: Prospective Evaluation of 90 Patients in 1 Year. J Neuroimmunol (2018) 321:157–63. doi: 10.1016/j.jneuroim.2018.04.016
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2018.04.016</ArticleId>
            <ArticleId IdType="pubmed">29793728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Long Y, Liang J, Xu H, Huang Q, Yang J, Gao C, et al. . Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Chinese Patients: A Retrospective Study. Eur J Neurol (2018) 25:477–83. doi: 10.1111/ene.13531
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.13531</ArticleId>
            <ArticleId IdType="pubmed">29193473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Iorio R, Damato V, Evoli A, Gessi M, Gaudino S, Di Lazzaro V, et al. . Clinical and Immunological Characteristics of the Spectrum of GFAP Autoimmunity: A Case Series of 22 Patients. J Neurol Neurosurg Psychiatry (2018) 89:138–46. doi: 10.1136/jnnp-2017-316583
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2017-316583</ArticleId>
            <ArticleId IdType="pubmed">28951498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kimura A, Takekoshi A, Yoshikura N, Hayashi Y, Shimohata T. Clinical Characteristics of Autoimmune GFAP Astrocytopathy. J Neuroimmunol (2019) 332:91–8. doi: 10.1016/j.jneuroim.2019.04.004
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2019.04.004</ArticleId>
            <ArticleId IdType="pubmed">30991306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kunchoka A, Zekeridoua,b A, McKeon A. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy. Curr Opin Neurol (2019) 32:452–8. doi: 10.1097/WCO.0000000000000676
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/WCO.0000000000000676</ArticleId>
            <ArticleId IdType="pmc">PMC6522205</ArticleId>
            <ArticleId IdType="pubmed">30724768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shan F, Long Y, Qiu W. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature. Front Immunol (2018) 9. doi: 10.3389/fimmu.2018.02802
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2018.02802</ArticleId>
            <ArticleId IdType="pmc">PMC6290896</ArticleId>
            <ArticleId IdType="pubmed">30568655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Savaş M, Tzartos J, Küçükali Cİ, Dursun E, Karagiorgou K, Gezen-Ak D, et al. . Glial Fbrillary Acidic Protein (GFAP)-antibody in Children With Focal Seizures of Undetermined Cause. Acta Neurol Belg (2020) 121(5):1275–80. doi: 10.1007/s13760-020-01361-y
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13760-020-01361-y</ArticleId>
            <ArticleId IdType="pubmed">32333263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yang X, Xu H, Ding M, Huang Q, Chen B, Yang H, et al. . Overlapping Autoimmune Syndromes in Patients With Glial Fibrillary Acidic Protein Antibodies. Front Neurol (2018) 9:251. doi: 10.3389/fneur.2018.00251
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2018.00251</ArticleId>
            <ArticleId IdType="pmc">PMC5932346</ArticleId>
            <ArticleId IdType="pubmed">29755396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Huang H, Bai K, Fu Y, Lu S, Ran Y, Dang H, et al. . GFAP Autoantibodies In Pediatric Patients. Front Pediatr (2020) 8:626564. doi: 10.3389/fped.2020.626564
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fped.2020.626564</ArticleId>
            <ArticleId IdType="pmc">PMC7868541</ArticleId>
            <ArticleId IdType="pubmed">33569363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Theroux LM, Goodkin HP, Heinan KC, Quigg M, Brenton JN. Extreme Delta Brush and Distinctive Imaging in a Pediatric Patient With Autoimmune GFAP Astrocytopathy. Mult Scler Relat Disord (2018) 26:121–3. doi: 10.1016/j.msard.2018.09.015
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2018.09.015</ArticleId>
            <ArticleId IdType="pubmed">30245384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yang X, Liang J, Huang Q, Xu H, Gao C, Long Y, et al. . Treatment of Autoimmune Glial Fifibrillary Acidic Protein Astrocytopathy: Follow-Up in 7 Cases. Neuroimmunomodulation (2017) 24:113–9. doi: 10.1159/000479948
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000479948</ArticleId>
            <ArticleId IdType="pubmed">28922662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ding J, Ren K, Wu J, Li H, Sun T, Yan Y, et al. . Overlapping Syndrome of MOG-IgG-associated Disease and Autoimmune GFAP Astrocytopathy. J Neurol (2020) 267(9):2589–93. doi: 10.1007/s00415-020-09869-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09869-2</ArticleId>
            <ArticleId IdType="pubmed">32378036</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
